Dr. Viterbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Avenue
Philadelphia, PA 19111Phone+1 215-728-6900
Summary
- Dr. Rosalia Viterbo is a Philadelphia-based Urologist specializing in minimally invasive surgery, infections and inflammation, and surgical oncology. She completed her medical education at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and her residencies and fellowship at Temple University Hospital and City of Hope National Medical Center. Dr. Viterbo is the Urologic oncologist and an Associate Professor at Temple University Health System. Her experience spans prostate cancer, gynecologic oncology, urologic oncology, to name a few. Dr. Viterbo has been recognized with honors, such as the CMS Meaningful Use Stage 1 Certification and a fellowship from the American College of Surgeons. She also has an active academic career with several peer-reviewed publications to her credit.
Education & Training
- City of Hope National Medical CenterFellowship, Complex General Surgical Oncology, 2006 - 2007
- Temple University HospitalResidency, Urology, 2002 - 2006
- Temple University HospitalResidency, Surgery, 2000 - 2002
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
- CA State Medical License 2006 - Present
- NJ State Medical License 2023 - 2025
- PA State Medical License 2001 - 2024
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 39 citationsCoexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal BiopsySerge Ginzburg, Robert G. Uzzo, Tahseen Al-Saleem, Essel Dulaimi, John Walton
The Journal of Urology. 2014-02-01 - 53 citationsDefects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H. Hoffman-Censits, Fern Anari, John O'Neill, Daniel M. Geynisman
European Urology Oncology. 2020-03-10 - 94 citationsActive Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical OutcomesAndrew McIntosh, Benjamin T. Ristau, Karen Ruth, Rachel Jennings, Eric A. Ross
European Urology. 2018-08-01
Journal Articles
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
Press Mentions
- Better Robotic RP Skills Linked to Better ResultsJuly 14th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: